Nadia Care raised $12 million in funding to expand its community-centered maternal care, the startup announced on Monday. The maternal health company is formerly known as Cayaba Care and offers care ...

New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial ...

Reframing transportation as infrastructure, not a support service, means holding it to the same standard as any other ...

Elevance Health is leveraging AI for simplifying the member experience, improving the provider experience and making sure ...

The FDA has expanded the approval of a targeted Gilead Sciences therapy as a new first-line treatment for triple-negative breast cancer, tightening competition with a rival drug from the same class ...

Upside, a housing stability platform partnering with health insurers, announced Thursday that it raised $20 million in Series A funding. The company’s AI-powered platform helps payers and employers ...

Cadence raised $100 million in Series C funding to scale its AI-powered chronic care platform, which monitors patients at ...

UniQure is preparing to seek accelerated FDA approval for its Huntington’s disease gene therapy, a move that follows the ...

Healthcare isn’t struggling to adopt AI. In fact, the industry has moved quickly from early experimentation to widespread investment in tools designed to improve clinical decision-making, reduce ...

Women wait an average of seven to ten years to be diagnosed with endometriosis. For PMOS, fibroids, perimenopause and dozens of other conditions, the story is similar, typically involving dismissed ...

On February 23, the FDA did something the rare disease community has spent a decade fighting for: it issued the Plausible Mechanism Framework, a formal pathway for individualized therapies where ...